| Family: | Invesco |
| Name: | Invesco Biotechnology & Genome ETF |
| Inception Date: | 23-Jun-2005 |
| Termination Date: | |
| Investment Objective: | The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November. |
| Prospectus | |
| Top 10 Holdings | ||
| Vertex Pharmaceuticals Inc | VRTX | 4.9700% |
| Amgen Inc | AMGN | 4.8300% |
| Royalty Pharma PLC | RPRX | 4.6800% |
| Regeneron Pharmaceuticals Inc | REGN | 4.6800% |
| Biogen Inc | BIIB | 4.6100% |
| Alnylam Pharmaceuticals Inc | ALNY | 4.5200% |
| Gilead Sciences Inc | GILD | 4.3400% |
| United Therapeutics Corp | UTHR | 4.2200% |
| BioTechne Corp | TECH | 3.6200% |
| Vericel Corp | VCEL | 3.2700% |
| Top 10 Holdings Weight: | 43.7% |
| Number of Holdings: | 34 |
| Shares Outstanding: | 3,140,000 |
| Total Net Assets: | 286,284,200 |
| NAV: | 91.16 |
| Net Expense Ratio: | 0.58% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | NYSE Intellidex proprietary model |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
